TYMS and lung carcinoma: KRT19, SPARC, SPOCK, LINC00707 (lung cancer promoting lincRNA), FOSL1 and AXL (identified as downstream targets of TS as they appeared in both signatures) were qPCR validated in both cell lines (Fig. 3c and Supplementary Fig. 3B).